The posts may have been racist, or, more chillingly, transphobic. I will withhold judgement, pending further information. The sentence may or may not be inappropriate.

Johnson’s body language and facial expression suggest that his discomfort and his only option is to reply with a deflecting whataboutism.

So far we have only heard one side of the story. Let's wait for more information before rendering judgement.

President Trump hasn't been seen in three days; since his speech at the generals meeting. https://rollcall.com/factbase/trump/topic/calendar/

@AndyD said in Completely random: and age-hunched this I have really noticed also. But, that is a natural part of aging, especially for someone who has not taken too good of care of himself.

See my post above. My guess is he will be settling for a nice round number.

https://www.aginganddisease.org/EN/10.14336/AD.2024.0642

@Axtremus said in HUD website right now: Just checking ... Still better than the alternative, right? No need to stress. I’ll tell you when it isn’t.

@jon-nyc said in Luxury jet replaces cabin windows with video screens: Or someone hacks it and puts the passengers in a giant porn scene. See? AI has some excellent uses!

RIP

Cool.

I have foresworn football and now follow WNBA. Speak not to me of those goons.

@jon-nyc said in Piano upgrade time: I think you’ll be better off buying there. Good call. I agree. A whole lot of bad things can happen in transcontinental shipping.

I was quite early when I started. The key is to be reachable and responsive. If you don’t hear back from me within a day you can be sure I’m in jail, hospital or lying in a ditch somewhere.

OK with deportation, not OK with Uganda.

said in TrumpRx: Interestingly Pfizer, GSK, Sanofi, and JnJ are all up today. Maybe they’re just screwing the retailers and the PBMs. There seem to be two theories as to why big pharma stocks are up. Theory A: “This represents a win for” Pfizer, Akash Tewari, a Jefferies analyst, wrote in a note to clients Wednesday. He estimated that offering some new drugs at internationally comparable prices could cost Pfizer up to $723 million a year. That would amount to just over 1 percent of Pfizer’s $63.6 billion revenue last year. Pfizer “may have done the rest of the industry a favor by giving a framework for a bespoke solution that we feel would be very tenable” for other big pharmaceutical companies and “would have a de minimis impact on their business going forward,” Tewari wrote. Details on the pact are scant and terms remain confidential: of the three Pfizer drugs to be sold at discounts and announced at this week’s news conference, none are top sellers. Many of the cuts Pfizer is promising are aimed at the government Medicaid program, which analysts say account for less than 5 percent of the company’s U.S. revenue. And Pfizer’s agreement to list discounted drugs for direct purchase on the president’s TrumpRx website resembles an initiative already being promoted by the industry. Theory B: A White House official characterized the rising Pfizer stock price as evidence that investors believe other countries will now “pay their fair share” as part of an international rebalancing of prices.

I paid $50 for skirt steaks for the three of us.

Memories of my folks outside on the patio. Kinda makes me smile. I was mixing Caesars, martinis for my parents from a pretty young age.

Some more background https://fortune.com/2025/10/01/charlie-javice-frank-jpmorgan-chase-fraud-prison-sentencing-speech/ Charlie Javice, the 33-year-old entrepreneur who once promised to revolutionize college financial-aid applications, tearfully apologized to JPMorgan Chase, its shareholders, her friends and family, and former employees of her startup, Frank, as she was sentenced to just over seven years in prison on Monday for orchestrating a $175 million fraud. “Not a day passes that I do not feel profound remorse,” Javice said through tears before U.S. District Judge Alvin Hellerstein in Manhattan federal court. Standing to address the court, she said she was “haunted that my failure has transformed something meaningful into something infamous” and admitted to making “a choice that I will spend my entire life regretting.” The sentencing marks a dramatic fall from grace for Javice, who once graced Forbes’ “30 Under 30” list in 2019 and was celebrated as a rising star in financial technology. Her startup Frank, founded in 2017, was designed to simplify the complex process of filling out the Free Application for Federal Student Aid (FAFSA) for college students seeking financial assistance. JPMorgan Chase acquired Frank in September 2021 for $175 million, believing the platform served more than 4 million students across 6,000 higher education institutions. However, prosecutors proved that Javice had fabricated the vast majority of those customers, with the actual number being fewer than 300,000. The deception unraveled when JPMorgan attempted to market its banking products to Frank’s supposed customer base. When the bank sent marketing emails to 400,000 purported Frank customers, approximately 70% bounced back as undeliverable. The bank’s investigation revealed that Javice had enlisted the help of a data science professor, paying him $18,000 to create fake customer data.